COCCO[C@H]1CC[C@@]2(C)C(=CCC3C4CC[C@](C)(O)[C@@]4(C)CCC32)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?